Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,052,296 papers from all fields of science
Search
Sign In
Create Free Account
beta-chimaerin
Known as:
beta 2-chimaerin
, beta2-chimaerin
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Narrower (1)
CHN2 protein, human
Broader (1)
Neoplasm Proteins
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
p23/Tmp21 Differentially Targets the Rac-GAP β2-Chimaerin and Protein Kinase C via Their C1 Domains
Hongbin Wang
,
M. Kazanietz
Molecular Biology of the Cell
2010
Corpus ID: 11977572
The ER/Golgi protein p23/Tmp21 acts as a C1 domain-docking protein that mediates perinuclear translocation of β-chimaerin. C1…
Expand
2010
2010
A Novel Cross-talk in Diacylglycerol Signaling
Erin M. Griner
,
M. C. Caino
,
+4 authors
M. Kazanietz
Journal of Biological Chemistry
2010
Corpus ID: 11792990
Although the family of chimaerin Rac-GAPs has recently gained significant attention for their involvement in development, cancer…
Expand
2009
2009
β2‐Chimaerin binds to EphA receptors and regulates cell migration
Shingo Takeuchi
,
Nao Yamaki
,
T. Iwasato
,
M. Negishi
,
H. Katoh
FEBS Letters
2009
Corpus ID: 12620044
2009
2009
Biochemical characterization of hyperactive beta2-chimaerin mutants revealed an enhanced exposure of C1 and Rac-GAP domains.
M. Sosa
,
N. Lewin
,
Sung-Hee Choi
,
P. Blumberg
,
M. Kazanietz
Biochemistry
2009
Corpus ID: 9619924
Recent studies established that the Rac-GAP beta2-chimaerin plays important roles in development, neuritogenesis, and cancer…
Expand
2007
2007
β2-Chimaerin in Cancer Signaling: Connecting Cell Adhesion and MAP Kinase Activation
Stephen P Bruinsma
,
T. Baranski
Cell Cycle
2007
Corpus ID: 38355159
The chimaerins are Rac GTPase-activating proteins that bind diacylglycerol. Emerging evidence implicates β2-chimaerin in tumor…
Expand
2007
2007
Diacylglycerol kinase gamma interacts with and activates beta2-chimaerin, a Rac-specific GAP, in response to epidermal growth factor.
S. Yasuda
,
M. Kai
,
S. Imai
,
H. Kanoh
,
F. Sakane
FEBS Letters
2007
Corpus ID: 1243130
Diacylglycerol kinase (DGK)gamma was shown to act as an upstream suppressor of Rac1. Here we report that, in COS7 cells…
Expand
2006
2006
Phospholipase Cgamma/diacylglycerol-dependent activation of beta2-chimaerin restricts EGF-induced Rac signaling.
Hongbin Wang
,
Chengfeng Yang
,
+4 authors
M. Kazanietz
EMBO Journal
2006
Corpus ID: 21379238
Although receptor-mediated regulation of small G-proteins and the cytoskeleton is intensively studied, the mechanisms for…
Expand
2005
2005
Role of β2-chimaerin in the behaviour of murine mammary carcinoma cells in response to extracellular matrix components
P. Menna
,
L. Y. Peche
,
D. Alonso
,
D. Gomez
2005
Corpus ID: 29811612
Chimaerins are high affinity receptors for phorbol esters and diacylglycerol (DAG), unrelated to the protein kinase C isozymes…
Expand
2002
2002
Interaction of the novel anthracycline antitumor agent N-benzyladriamycin-14-valerate with the C1-regulatory domain of protein kinase C: structural requirements, isoform specificity, and correlation…
J. Roaten
,
M. Kazanietz
,
+5 authors
T. Sweatman
Molecular Cancer Therapeutics
2002
Corpus ID: 24611235
Anthracycline antibiotics like doxorubicin (DOX) are known to exert their antitumor effects primarily via DNA intercalation and…
Expand
2001
2001
Molecular models of N-benzyladriamycin-14-valerate (AD 198) in complex with the phorbol ester-binding C1b domain of protein kinase C-delta.
J. Roaten
,
M. Kazanietz
,
T. Sweatman
,
L. Lothstein
,
M. Israel
,
A. Parrill
Journal of Medicinal Chemistry
2001
Corpus ID: 19948590
N-Benzyladriamycin-14-valerate (AD 198) is a semisynthetic anthracycline with experimental antitumor activity superior to that of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE